Iridium‐Catalyzed Reductive Deoxygenation of Esters for the Synthesis of Sterically Hindered Ethers
The synthesis of sterically hindered α-tertiary and β-quaternary (neopentylic) ethers has long been constrained by the limitations of traditional S<sub>N</sub>2 and related S<sub>N</sub>1 approaches, namely low or inexistent reactivity arising from severe steric hindrance or competitive elimination/rearrangement pathways diverting the reaction outcome. Herein, we describe a general solution to the synthesis of sterically hindered ethers via an iridium-catalyzed reductive deoxygenation reaction of readily available ester and lactone starting materials. Employing commercially available, bench-stable IrCl(CO)(P[OCH(CF<sub>3</sub>)<sub>2</sub>]<sub>3</sub>)<sub>2</sub> as a precatalyst at 1 mol% loading with 4 equivalents of tetramethyldisiloxane (TMDS) as the terminal reductant at room temperature, this practical synthetic approach to hindered ethers features a simple, mix-and-stir, single-vessel protocol under ambient conditions and produces a diverse range of both acyclic and cyclic ether products in good to excellent yields. Control experiments demonstrated that the IrCl(CO)(P[OCH(CF<sub>3</sub>)<sub>2</sub>]<sub>3</sub>)<sub>2</sub>/TMDS catalytic system could not only rapidly hydrosilylate esters to mixed silyl/alkyl hemiacetal intermediates but also catalyze the reduction of acetals directly to ethers, revealing the Lewis acidic and hydridic properties required for this deoxygenative transformation.
Authors
- Darren J. Dixon (ORCID: https://orcid.org/0000-0003-2456-5236)
- Pablo Gabriel (ORCID: https://orcid.org/0000-0002-3462-5151)
- Yaseen A. Almehmadi (ORCID: https://orcid.org/0000-0002-9094-8393)
- Anna J. Passmore
Institutions
- King Abdulaziz University (SA)
- University of Oxford (GB)
Publication Details
- Journal
- Angewandte Chemie International Edition
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1002/anie.202508301
- Primary Topic
- Advanced Synthetic Organic Chemistry
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Diamond Light Source
- King Abdulaziz University
- Defence Science and Technology Laboratory
- Engineering and Physical Sciences Research Council
- Defence Science and Technology Group